Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2001

View Archived Issues

Genome-derived candidate for oncology identified as part of Millennium/Bayer alliance

Telik and the University of Arizona enter TRAP alliance

Human Genome Sciences licenses protein purification technology from Dyax

Update on Active Biotech's TTS products under clinical development

GlaxoSmithKline acquisition of Block Drug completed

Biogen expects product pipeline to double during 2001

Vion provides update of clinical programs

Results of phase III Metvix study show superiority to cryotherapy in treatment of AK

FDA approves Remeron SolTab for treatment of depression

Atrisone advances to phase III testing in acne

Continuous combined HRT with Climodien cleared for marketing in The Netherlands

Development of Merck compound for PD discontinued

Details on proposed merger of Medi-Ject and Permatec

Arakis and Bioglan Pharma to jointly develop novel psoriasis treatment

Pagoclone enters phase II for treatment of GAD

Arena receives second milestone payment from Lilly in CART collaboration

IntraBiotics completes patient enrollment in phase III Protegrin IB-367 Rinse study

Antex receives SBIR grant to develop microbead vaccine for traveler's diarrhea

Exclusive rights to NX-211 obtained by Gilead from GSK

First tablet preparation for bowel cleansing prior to colonoscopy now available in U.S.

Newly designed HIV-1 entry inhibitor holds great promise for clinical application

Monoclonal antibodies to alpha1 integrin designed at Biogen for inflammatory disorders

Adenosine uptake inhibitors useful for cerebral ischemia patented by Bayer

New oxazaheterocyle-based protease inhibitors reported by 3DP group

Antimicrobial series in development at Pharmacia

Anticancer compounds from Boehringer Ingelheim acting on kinases

Novel tryptase inhibitors with potential in therapy of influenza

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...